China Healthcare Weekly (Oct.9)
This insight summarized the important industry viewpoints, news of listed healthcare companies and capital market review for the last week of China...
239 Views
JHBP Holdings (Genor Biopharma) IPO Initiation: Hunting for a Cure
$ Genor Biopharma is a biopharmaceutical company focusing on developing and commercializing oncology and autoimmune drugs. Its drug candidates...
452 Views
Trade Idea: Short Henlius Upon Lock-Up Expiry & 2H Results, HLX01 Likely Underperformed
Shanghai Henlius Biotech (2696 HK) IPO lock-up will expire on 25th of March, six months post its listing. The stock has been underwater since...
358 Views
InnoCare (诺诚健华) IPO: Bifurcated Book, Update of Our View
InnoCare launched the book building on March 11th to raise up to USD 288 million to list in Hong Kong. Book building will end on March 16...
459 Views
Alphamab Oncology IPO: Valuation Easy to Swallow
Alphamab Co Ltd (9966 HK) is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...
535 Views